Showing posts with label biotechnology. Show all posts
Showing posts with label biotechnology. Show all posts

February 18, 2012

Science on stage: experts and diversity (or lack thereof)



The National Academy of Sciences (NAS) is considered one of the most (if not the) prestigious groups of scientists in the US. The National Research Council, their research arm, produces reports that are ostensibly the pinnacle of objectivity and scientific rigor. But Steve Hilgartner, in his book Science on Stage, aims to show that even the pinnacle of scientific objectivity is still dependent on social processes. While the NAS are considered knowledge experts, you don’t see behind the curtain. Hilgartner uses the metaphor of stage management, where the NAS staff, scientists, and report contributors carefully manage the end products. Deciding something like what nutritional standards to recommend is obviously not only value-laden, but is also under pressure from politically motivated food lobby groups, as Marion Nestle shows in her book, Food Politics.

The NAS doesn’t use overt political rhetoric. Like most scientists, they strive to be as objective as possible. But Hilgartner shows that making knowledge claims is political. The NAS uses certain rhetoric to reify their role as sanctioned experts, and to eliminate sources of controversy. In an anthropology class I once took, we referred to this as impression management. Like Hilgartner’s “stage management,” we often consciously and unconsciously say and do things to create a certain impression of ourselves in different situations. Scientists engage in the same social process.

So is the NAS’s stage management technique problematic? Among STS scholars, the answer is “yes.” In fact, James Wilsdon and Rebecca Willis produced a booklet called “See-Through Science,” which calls of “upstream engagement” in science policy. As we discussed in class, this call for more transparent scientific processes and more space for public deliberation. Two topics we’ve discussed in class: community-based participatory research and Hispanic girls’ engagement in science and engineering, both seek to make science more open and transparent to diverse populations. And already, it’s obvious that the academy is slowly reacting to pressures to become more open.

In the recent past, most decisions about science policy have been made by a small group of people: mostly white, mostly male scientists. In 1975 at the recommendation of the NAS, eminent biochemist Paul Berg organized the well-known Asilomar conference to discuss the ethical implications of biotechnology. The conference was attended by almost entirely white male scientists. Wilsdon and Willis quote Sheila Jasanoff, writing, “Thirty years and several social upheavals later, the Berg committeeΚΌs composition looks astonishingly narrow: eleven male scientists of stellar credentials, all already active in rDNA experimentation” (p. 10). In other words, today we expect decisions about science policy to be made by not only experts, but also issue stakeholders of diverse interests and backgrounds.

Jasanoff’s words resonate with a current issue: the debate over insurance coverage of contraceptives. Many of my Facebook friends have posted responses to this photo, citing the injustice that not a single woman was able to testify to Congressional committee on this issue of contraceptive coverage and religion. The online commentary is very much along the lines of “what is this, 1950?” At a time where women do have expertise in areas such as law, science, and religion, they are still not allowed in front of the curtain.

Works referenced:
Stephen Hilgartner, Scienceon Stage: Expert Advice as Public Drama (Stanford, 2000).

Kathy Wilson Peacock, GlobalIssues in Biotechnology and Genetic Engineering. (New York: Infobase Publishing, 2010).

January 30, 2012

STS perspectives on the Green Revolution

Over the next few weeks, you'll be hearing a lot from me and some collaborators about the future of food and agriculture. Consider this a warm-up, although it's a bit academic. And if you're in the Phoenix area, check out this panel I'm participating in this week, "Feed 8 Billion."

The Green Revolution is an era of rapid agricultural innovation and diffusion that is critical to my own research, and I would argue, to the future of agricultural research. Narratives of the Green Revolution are invoked by different actors for different purposes; Robert Zeigler might invoke the Green Revolution as a reason to support public agricultural research. Activists like Vandana Shiva might invoke it to warn of the dangers of monocropped agriculture and top-down international development projects. I prefer to take the middle road, but the aim of my research is not to make a normative judgment about the Green Revolution. Instead, I aim to interpret how different visions of agricultural change and innovation drive organizations and technological development.

I have created a public folder of my essential Green Revolution articles, and I would also highly recommend these books by Kloppenburg, Perkins, and Cullather for an even richer perspective. There are so many things written about this topic, but I've attempted to cull it down to my favorites. I've also included my paper on the Green Revolution and the Population Bomb in Asia from 1960-1970, which I wrote for a class last year and hope to turn into a dissertation chapter. Please ask for permission if you'd like to cite or circulate my paper.

I'm going to highlight 3 papers for this post. They are articles I picked because they cover the basics of the Green Revolution, biotechnology, globalization, and some of the core STS concepts I want to explore in my research. The common theme between these 3 articles is agricultural innovation systems, and the dynamic between technologies and institutions/organizations.

Let’s start with Parayil’s 2003 paper on technological trajectories from the Green Revolution to the “Gene Revolution” (biotechnology and molecular techniques for plant breeding). Parayil borrows the concept of technological trajectories from a paper by Giovanni Dosi in 1982. The unique contribution of Dosi’s theory is that technological development occurs in a specific technological paradigm that both produces innovations, but also constrains these innovations to a specific trajectory. The physical properties of the technology and its path of development, the institutional environment that produce technologies, and the economic forces driving innovation all contribute to a specific technological trajectory. 

Parayil uses this theoretical framework to explain how the research organizations, technologies, and economic incentives during the Green Revolution are very different than today’s Gene Revolution. Other factors, like globalization, neoliberalism, and intellectual property rights also characterize today’s innovation environment. To Parayil, it is wrong and possibly dangerous to imagine the Gene Revolution as a continuation of the Green Revolution. I am proposing to empirically study an actual innovation system, using the case study of northwest India. What actors are involved in research, seed sales, and extension? To what extent are farmers included in participatory research, and does this feed back into the system? How do conceptions of biotechnology and the Green Revolution shape future imaginations of agricultural adaptation to climate change?

Onto the next article, Brooks (2011) on international agricultural research and global public goods (GPGs). Brooks discussed how the CGIAR (an international consortium of public agricultural research centers, several of which were critically involved in the Green Revolution) markets itself as a purveyor of GPGs and that the “CGIAR centres would now play a ‘brokering’ role in global, heterogeneous networks comprising a wide range of public and private institutions (Rijsberman 2002, 3). The implication was that ‘the CGIAR was uniquely placed to act as honest broker’ and steer these complex networks in directions consistent with a public goods research mandate (Brooks 2010, 4)” (Brooks, 2011, 70). Brooks frames her argument against a 2008 paper by Dana Dalrymple, an economist at the USDA who has promoted public international agricultural research since the Green Revolution. 

She uses the case studies of Golden Rice, iron biofortification, and the CGIAR’s HarvestPlus program to show how despite the CGIAR’s claims of knowledge brokering and new research paradigms, and despite ostensibly new research partnerships and institutional innovations, the CGIAR has maintained both institutional dominance (in a top-down paradigm) and technological and economic reductionism (assuming scale-neutral technologies, and silver bullet solutions to complex social problems). My research on climate change adaptation and agricultural research aims to uncover similar dynamics. How do international, national, and local agricultural research organizations (including public, private, and NGOs) use climate change as a leverage point for power? Have research paradigms actually changed because of climate change, or are the same technological and institutional goals maintained? 

Finally, Busch and Juska (1997) discuss political economy, actor network theory, and globalized food and agricultural systems. The authors frame their article against political economy approaches, which focus on social power. They claim that this approach generalizes and simplifies the range of actors involved, and demands that non-human actors (such as food and nature) are passive. Instead, they recommend embracing actor network theory, which seeks to remedy these oversights. They use the case study of Canadian rapeseed (canola) to show the relationships between scientific institutions (particularly plant breeding and organic chemistry), technologies, and nature that were necessary to make rapeseed oil edible for humans. Furthermore, the liberalization of global rapeseed markets led to shifts in production and consumption. I find the actor network theory approach to agricultural systems extremely helpful in empirically conceptualizing the connections between scientific research, commodity chains, and producers and consumers. In my own research, I plan on conducting a network analysis of rice and wheat research in northwest India. I’m not as interested in the global commodity chain, but rather the interaction between local, national, and international actors.

October 8, 2011

Genetically modified foods and public engagement


A great blog you should check out this weekend is Jack Stilgoe's "Responsible Innovation." My grad colleagues and I recently enjoyed discussing his "'How' technologies and 'Why' technologies." An excerpt:
Some emerging technologies are defined by how they do things. So called ‘platform-technologies’ or ‘enabling technologies’ like synthetic biology provide new ways of doing a whole lot of different stuff.... Geoengineering, on the other hand, is defined by its intentions (I wrote about this here). Its target is a future in which we are able to influence the climate. This doesn’t mean that geoengineering researchers desire this future. Many of them would despise such a prospect. But they are interested in it. So while nano and syn bio are defined by the how, geo is defined by its why. This invites different sorts of governance and difference sorts of public engagement.
But his recent post that really intrigued me was an interview with Stilgoe on engaging the public in dialogues about genetically modified (GM) foods. Stilgoe discusses how going into a public dialogue about GM foods is different than with a more politically-neutral, or less entrenched, topic (see my previous post on GM and risk; also see my post on public dialogues). He also talks about "upstream engagement," which means involving the public in science throughout the research process, rather than just dealing with the possible consequences of the results. On engaging with stakeholders:
[Q:] The report speaks of engagement with both stakeholders and the public. In the case of GM, what do you perceive to be the difference, and do we need a different approach for each? 
[Stilgoe:] Absolutely we need a different approach for each. When you are engaging upstream, everyone is a potential stakeholder; yet at the same time there are no obvious direct stakeholders because there isn’t anything yet for people to have a stake in, except researchers and the people who govern that research. In a downstream discussion like GM, there are clearly established stakeholders: farmers, regulators, politicians, interest groups, supermarkets, and animal feed companies who all need to find a way to thrash things out in a fairly old fashioned way. I think that confusing this activity with public engagement is unhelpful and puts far too large a burden on public engagement. 
I think there’s another important set of lessons that need to be learnt which we didn’t cover in the report, particularly about how to engage with stakeholders. These more controversial issues involve direct action, lobbying and engagement in ‘uninvited spaces’ that government is not controlling and is less comfortable with. With an issue such as GM, working out mechanisms for this form of engagement may be more important than convening a formal public dialogue.
Really interesting stuff to think about! Have a good weekend!

October 3, 2011

Defining my research question Part II


My big project of this semester is writing my prospectus, which is a full-length research proposal that I will later present and defend in front of my committee. I'm also working on my NSF GRFP proposal, which I got an honorable mention for last year and am really working on right now. So I'm working on the "big picture" prospectus, and then cramming it all into a 2-page (with detailed methodology, of course) research proposal for the NSF. Today I gave a presentation about my research, and was highly encouraged to look not only at public research organizations, but private as well. They looked at my figure (above) and asked the glaring question: where would a company like Monsanto be? I think we're onto something, so here goes...

Question 
How do crop varieties that are developed for short-term weather variability become promoted as a long-term climate adaptation strategy? What is the role of, and interaction between, international public and private research organizations in developing and promoting these varieties?

Motivating context
My research question revolves specifically around technological innovations in plant genetics, which are often promoted as a solution to climate change adaptation in agriculture. Drought-resistant, flood-tolerant, salt-tolerant, and heat-tolerant varieties can improve plant responses to weather variability, which is expected to increase under climate change. My research will examine how climate change is addressed in plant genetic research in the agricultural innovation system, and some of the farm-level implications of these technologies.

‘Agricultural innovation systems’ are typically viewed as the research pipeline from public international, to national, to local research and extension systems. The international research centers provide a centralized hub of knowledge production and, critically, innovations in plant genetics. Plant genetic improvement—such as “modern” (high-yielding) crop varieties, hybrids, and transgenics—has guided agricultural innovation systems over the past century. This concept has captured the imagination of scientists, policy-makers, and the public alike since the Green Revolution.

However, today’s agricultural innovation system is much more complex than the linear research pipeline. Farmers now participate in plant breeding research, and non-governmental organizations and private seed companies work in parallel with the public, Green Revolution-style research and extension infrastructure. Notably, the introduction of patents and intellectual property rights on genes and plant varieties frustrates the public-good-oriented public agricultural research, while providing an economic incentive for private agricultural research. The result is not a bifurcation of research goals, but rather a collaboration of public, private, and other agricultural organizations woven together in a “triple-helix” model of innovation, rather than the linear model. For example, this article shows the interactions between public and private research and funding:
Monsanto and BASF, for instance, are working with the International Maize and Wheat Improvement Center and national agricultural research programs in Kenya, Uganda, Tanzania, and South Africa to develop drought-tolerant corn. The program is supported by a $47 million grant from the Bill and Melinda Gates Foundation. In March this year, the African Agricultural Technology Foundation announced that Monsanto and BASF have agreed to donate royalty-free drought-tolerant transgenes to the African researchers.
Innovation theory
The Hayami-Ruttan “Induced Innovation Hypothesis” seeks to explain how “supply” and “demand” factors influence the development of new agriculturally technologies. On the “supply” side is scientific agricultural research. On the “demand” side is farmers’ willingness to adopt new innovations. “Climate,” and other environmental forces, also affects the “demands” of agriculture, imposing new conditions that limit or provide opportunities for innovations. Can Hayami-Ruttan’s hypothesis provide insight into where we expect innovations to happen in the research pipeline, in light of the new organizational and institutional arrangements?

So what?
We imagine futures based on current technologies and past trajectories, thus certain innovations get “locked-in” and others “locked-out” of research and development. While climate is a relevant variable in the future of agriculture, it is not the only variable, especially in light of farmer livelihoods and the complexities of climate change adaptation and the overall resilience of agro-ecological systems. How does climate change influence farmers’ adoption of new crops, and facilitate or hamper longer-term climate adaptation strategies?


Further reading:
Parayil, G. (2003). Mapping technological trajectories of the Green Revolution and the Gene Revolution from modernization to globalization. Research Policy, 32, 971-990.

August 29, 2011

Is agricultural technology the answer to Malthus?

Just a quick update today, based on some interesting articles I've come across related to agricultural technology and climate change. To start, maybe you'd like to refresh your memory with some of my previous posts on this topic? For a few years now, I've been following news articles about agriculture and climate change, and I'm noticing a pretty obvious theme. Biotechnology(!) Climate models(!) Nanotechnology(!) and other promising new technologies in the pipeline are heralded as the next big thing in adapting agriculture to climate change. Listen, I don't want to sound like a ranting environmentalist here, but I believe there's value in taking a slightly more critical approach to these technological fixes. As I've said before, technology and technological innovation plays a hugely important role in global agriculture. Yet social contexts of innovation are equally important.

Rodrigo Cortes-Lobos, a graduate student at Georgia Institute of Technology, explores this is at CSPO's Soapbox. He proposes a participatory, adaptive management approach to developing agricultural technologies for smallholder farmers:
No matter the location, small farmers require new technology development, but under frameworks that foresee potential risks or disadvantage that the new technology can produce, with enough time to amend those negative consequences before the cost to the users is too high.
Related, here's an interesting article on the importance of farmer communication networks in adopting innovations: in this case, a radio program about new agricultural technologies.

Finally, two articles on food prices, climate change, and Malthusian predictions. This NYTimes article is from a few weeks ago, on Jeremy Grantham and his reframing of climate change as a resource depletion issue. His argument seems to be that if we can frame it this way, it will attract rich investors who respond to market signals. Grantham reflects classic neo-Malthusian views about population growth, soil degradation, and now climate change. He is hoping for a second Green Revolution, driven by commodity markets. The second article is by Michael J. Roberts, an agricultural economist and writer of this blog. Roberts has a great analysis of food price volatility, market signals, and climate change. But his proposed policy solutions are as follows:
First, we could restore some of the funding to crop sciences. Research dollars could be directed toward the basic research that private companies are less inclined to undertake. Some might also be aimed at developing crop varieties more tolerant of warmer temperatures. 
Second, we could persuade countries to reform their processes for approving new genetically modified crops. Ingo Potrykus’s genetically engineered golden rice, developed in 1999, promises to substantially reduce the millions of deaths worldwide each year that stem from vitamin A deficiency. But due to regulatory hurdles, this life-saving variety of rice will not reach the market until at least next year.
Sure, it might be great if we could have global regulatory standards for GMOs. But the likelihood of this happening? GMOs are one of the most value-laden, contentious topics in agriculture. Patent rights are a huge problem. And when are we going to get over Golden Rice? The chances of it ever significantly catching on seem to be getting slimmer. As for funding more basic research, it's one of the easiest to make because it sounds so apolitical. But research, from the outset, can be inherently political. Scientists and donors are driven by humanitarian pursuits, but how do we know they are the right ones? Who gets to decide what are appropriate research goals? Is it possible to ignore the reality that private research is driving the global agricultural agenda? Why are we so obsessed with sustaining staple crop production in regions that are struggling to keep up with market prices as is? What about developing livelihoods rather than substituting technological inputs? 

I'm wondering whether this blog post comes off as ranting? My goal is not to be anti-science or technology at all; but I think anytime we bring up accepted tropes such as Malthusianism, the Tragedy of the Commons, and other narratives that really don't have any empirical backing (again, "miracle rice"), it's worth delving a little deeper into these embedded assumptions about human behavior.

[UPDATE]
Here's some interesting opposing viewpoints to Malthus. Population: more than a number. Agroecology as the next green revolution. An academic article on agricultural research and technological lock-in. World Bank paper on seeds, biodiversity, and patents.

I promise that the pika blog post is coming soon! In the meantime, do a google image search for pikas.

June 28, 2011

Risk, uncertainty, and value judgements in science policy

Yesterday my colleagues and I at Michigan State University and Kellogg Biological Station had a reading group to discuss Pielke's The Honest Broker. We read chapters 4-6 for today, which are titled, "4) Values; 5) Uncertainty; and 6) How science policy shapes science in policy and politics."


We talked about whether science is a good tool in making decisions. Certainly it can be good for informing decisions, such as if there's a tornado coming and you need to know whether you should evacuate. Unfortunately, as we saw in one of my previous posts, sometimes scientific assessments of risk and uncertainty do NOT translate well into action. Pielke agrees with this perspective. He thinks that science just adds smoke and mirrors to debates that are really about core values. So unless the situation under debate is one with low uncertainty and highly shared values (a tornado is coming, we should evacuate), we need more recognition of the underlying values of a debate (see: the climate change debate).

Pielke repeatedly refers to two works by Dan Sarewitz, who is one of my professors at Arizona State and regarded by many as a science policy guru. The first article is "How science makes environmental controversies worse" (2004). The second is "Science and Environmental Policy: An Excess of Objectivity" (2000). Both are worth a thorough reading: one thing I've discovered in grad school is that I sometimes read the same article months, or a year, apart, and find revelatory new nuggets of knowledge each time I read it.
The "Excess of Objectivity" book chapter is an insightful commentary on how science can actually impede the political process, by focusing on always disputable and uncertain facts while ignoring underlying value conflicts in highly politicized environmental issues. The “excess of objectivity” refers to the incompatibility of multiple fields of science, and how while each field claims objectivity, they drive controversy and muddy the political waters.

"How science makes environmental controversies worse" makes the same core argument, using a set of different examples from the 2000 election results, to climate change, to genetically modified food (another good case study is the debate over nuclear waste: see this editorial). This discussion reminded me of an article I read during my first weeks of grad school, "Value Judgments and Risk Comparisons. The Case of Genetically Engineered Crops" (2003) by Paul Thompson, who is an environmental and agricultural philosopher at MSU.


I wrote up an analysis of it that I think highlights the issues of value, risk, and uncertainty in environmental controversies pretty well: Thompson focuses on the inherent value judgments that scientists make about genetically engineered (GE) crops and environmental risk. He aims to identify the values behind the GE debate, rather than taking a philosophical or scientific position in the debate. He focuses on a relatively small aspect of this debate, which are claims for and against a comparative evaluation of the environmental risk of GE vs. traditional (non-GE) crops. This is the standard metric used by scientists and federal agencies to assess the risk of GE crops. Thompson’s argument is that risk assessments are inherently based on value-based judgments; the science itself cannot settle a claim about environmental risks.

He shows that the current regulatory system ironically puts the burden of proof on anti-GE activists, who are “in the position of needing to justify special treatment for this class of plants” (emphasize added, Thompson, 2003, p. 11). This gap charges the largely non-scientific public with demonstrating the scientific credibility of their value system, against the grain of the values held by the scientific community, which of course causes further problems on multiple levels. Thompson identifies several other challenges in the regulation of GE crops based on the current framework.

Risk assessments, especially environmental risk assessments, depend on value-based judgments of how much and what types of risk are “acceptable,” despite attempts to scientifically quantify this risk. The definitions of risk by the scientists and activists are essentially incompatible for comparing the risks of GM vs. non-GM crops, or even defining the concept of environmental risk. This highlights very clearly that science, rather than aiding the decision-making process, can complicate and add uncertainty to political debates.

On a related note, I'm headed to Boston today to attend the Science and Democracy Network conference! I'm really excited to talk to like-minded scholars about our work, and make some great connections.

June 24, 2011

4) Science and Public Value



A friend of mine asked about my last post on the "co-production" of knowledge, "who then 'owns' the research or is it always a public resource after co-production?”

Great question, and one that scholars have been struggling with especially in light of patents on genes and other biotechnology, such as genetically modified foods. This is generally referred to as "intellectual property" or "intellectual property rights" (IPR). Patents are supposed to protect the inventor and fuel innovation, but the case lately has been an increasingly convoluted fight over patent law, with "patent sharks" prowling for unclaimed discoveries that they can later sue companies for using. The figure below demonstrates some of the craziness in just smart phones:

But what happens when a drug company asks an indigenous tribe about their medicinal plants, and then goes on to patent and produce the medicinal compound? Or when patients donate their DNA to a study, only to be charged later for a test or treatment because a biotech company has patented the blueprint of the gene that causes cancer? Who should "own" that knowledge?

These are questions that modern governments are dealing with for the first time due to technological advances. Public research organizations are dealing with them as well: for example, the public agricultural research system that is largely responsible for last century's "Green Revolution" now must be more cautious about what agricultural technologies they can use, because of all the patents. Richard Jefferson is someone who understands this problem and is creating innovative solutions that benefit poor countries. He started a company that promotes "open source biology" by patenting discoveries in agricultural science, but then making those discoveries public. Some excerpts from this paper:
Most critically, we must democratize these abilities, both to measure and to respond, in order to diversify agro-ecosystems and environments and decentralize the problem-solving capability. We will achieve this by fostering scientific method and harnessing local knowledge and commitment in communities that have previously been ignored or treated as passive recipients of help. (p. 38)

At the start of the twenty-first century, science is at a critical juncture. Four centuries of inquiry, discovery, and invention have created a base of knowledge that has the potential to provide people everywhere, in all circumstances, with nourishment, improved health, and longer life. But the institutional mechanisms that ostensibly exist to encourage the application of science to practical problems are today hindering that very process. The norms that have evolved around gate-keeping have created new clergy, new impediments and new inefficiencies. Without a systemic change, science’s promise will not be available for those who most need it, and the promise of a truly diverse, robust and fair innovation culture may elude us. (p. 40)

This all boils down to a question of science and the public good. The "social contract of science" is an unspoken agreement that science, in the end, will produce public good. As the environmental movement often points out, science sometimes produces public bads. Or it doesn't produce the hoped-for goods. For example, “there are 6000 patents that invoke ‘plant breeding’ and ‘drought resistance’ yet none of them has yet resulted in an improved commercial variety” (Clark et al., p. 10). Agricultural extension programs do unique boundary work that is affected by both private and public interests. The private sector is crucial to developing new, useful technologies for farmers. Agricultural research institutions must increasingly embrace their role as a mediator between the private realm of gene patents and their goal of developing agricultural technologies for the public good.

More broadly, many of my colleagues at ASU's Consortium for Science, Policy, and Outcomes are working on this issue of science and public value. A recent issue of the journal Minerva featured their work, and a short review is available here. Also, this very-readable report by a British think-tank called Demos takes a Science & Technology Studies perspective on this topic. They tackle head-on provocative questions that I've been exploring throughout this blog:
Science has major social benefits and thus ‘public value’. Yet crucially, as recent controversies have underlined, this value cannot be assumed and taken as automatic, no matter what scientific research is done, or under what conditions. We need therefore to shift from noun to adjective, by asking not only: what is the public value of science? But also, what would public value science look like? (p. 29)